» Articles » PMID: 36277185

Genetic Insights into Non-syndromic Tetralogy of Fallot

Overview
Journal Front Physiol
Date 2022 Oct 24
PMID 36277185
Authors
Affiliations
Soon will be listed here.
Abstract

Congenital heart defects (CHD) include structural abnormalities of the heart or/and great vessels that are present at birth. CHD affects around 1% of all newborns worldwide. Tetralogy of Fallot (TOF) is the most prevalent cyanotic congenital cardiac abnormality, affecting three out of every 10,000 live infants with a prevalence rate of 5-10% of all congenital cardiac defects. The four hallmark characteristics of TOF are: right ventricular hypertrophy, pulmonary stenosis, ventricular septal defect, and overriding aorta. Approximately 20% of cases of TOF are associated with a known disease or chromosomal abnormality, with the remaining 80% of TOF cases being non-syndromic, with no known aetiology. Relatively few TOF patients have been studied, and little is known about critical causative genes for non-syndromic TOF. However, rare genetic variants have been identified as significant risk factors for CHD, and are likely to cause some cases of TOF. Therefore, this review aims to provide an update on well-characterized genes and the most recent variants identified for non-syndromic TOF.

Citing Articles

Gene Variants Predispose Individuals to Tetralogy of Fallot.

Feng Z, Huang X, Gao Y, Gao H, Na W, Tan C Phenomics. 2025; 4(6):548-561.

PMID: 40061823 PMC: 11889330. DOI: 10.1007/s43657-024-00175-9.


Detection of Genetic Variations in Children with Tetralogy of Fallot Using Whole Exome Sequencing Technology Integrated Bioinformatics Analysis.

Abdullahi K, Ali A, Adan M, Shu Q Genet Test Mol Biomarkers. 2024; 28(12):474-484.

PMID: 39653367 PMC: 11659463. DOI: 10.1089/gtmb.2024.0350.


Valvulopathies and Genetics: Where are We?.

Coll M, Fernandez-Falgueras A, Iglesias A, Brugada R Rev Cardiovasc Med. 2024; 25(2):40.

PMID: 39077344 PMC: 11263169. DOI: 10.31083/j.rcm2502040.


Integrative metabolomics dictate distinctive signature profiles in patients with Tetralogy of Fallot.

Li Y, Tian M, Zhou Z, Tu J, Zhang R, Huang Y Pediatr Res. 2024; .

PMID: 38951655 DOI: 10.1038/s41390-024-03328-8.


Genetic insights into Tetralogy of Fallot: Oh MYH(6).

Mital R, Lozier J, Mead T Pediatr Res. 2024; 96(2):297-298.

PMID: 38600301 PMC: 11343695. DOI: 10.1038/s41390-024-03195-3.


References
1.
Clark C, Zhang B, Lee B, Evans S, Lassar A, Lee K . Evolutionary conservation of Nkx2.5 autoregulation in the second heart field. Dev Biol. 2012; 374(1):198-209. PMC: 3549048. DOI: 10.1016/j.ydbio.2012.11.007. View

2.
Oechslin E, Attenhofer Jost C, Rojas J, Kaufmann P, Jenni R . Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000; 36(2):493-500. DOI: 10.1016/s0735-1097(00)00755-5. View

3.
Topf A, Griffin H, Glen E, Soemedi R, Brown D, Hall D . Functionally significant, rare transcription factor variants in tetralogy of Fallot. PLoS One. 2014; 9(8):e95453. PMC: 4122343. DOI: 10.1371/journal.pone.0095453. View

4.
Ho C, Day S, Ashley E, Michels M, Pereira A, Jacoby D . Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)". Circulation. 2019; 139(12):1559-1560. PMC: 6445361. DOI: 10.1161/CIRCULATIONAHA.118.039069. View

5.
Dentice M, Cordeddu V, Rosica A, Ferrara A, Santarpia L, Salvatore D . Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis. J Clin Endocrinol Metab. 2006; 91(4):1428-33. DOI: 10.1210/jc.2005-1350. View